- provides a secure and clean atmosphere for compounding of harmful drug preparations in compliance with USP and conditions. It is actually suitable for operate involving harmful products, antineoplastic, or cytotoxic compounding apps. The WHO's pointers provide not merely as a regulatory framework but will also being a roadmap Successfully Submitted (Awaiting Approval)